Product
Supplier
Encyclopedia
Inquiry
Tirzepatide-ECHEMI buy - large image1
Tirzepatide-ECHEMI buy - image1

Tirzepatide-ECHEMI

1967 Inquiries

Unit Price: Get Latest Price
CAS No.:

2023788-19-2

Grade:

Pharmaceutical Grade

Port:

Any China Port

Packaging:

100 G/ BAG

Price valid (until):

2024-12-06

Company Type:
Distributor
Location:
China
Qualification:
Main Products:

API,Intermediate

  • Product Description

  • Seller Information

  • Inquiry History

  • Description


      Product Detail  


    Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1

    (GLP-1) receptor agonist. Dual GIP/GLP-1 agonists gained increasing attention as new therapeutic agents for

    glycemic and weight control as they demonstrated better glucose control and weight loss compared to

    selective GLP-1 receptor agonists in preclinical and clinical trials.


    Tirzepatide comprises a 39 amino acid linear synthetic peptide conjugated to a C20 fatty diacid moiety. Its

    protein sequence was based on the sequence of endogenous GIP, and its pharmacological action on GLP-1

    receptors is comparable to endogenous GIP; however, the long half-life of Tirzepatide allows for once-

    weekly dosing. Tirzepatide was approved by the FDA on May 13, 2022, for the treatment of adults with type

    2 diabetes, making it the first and only GIP and GLP-1 receptor agonist for this indication. On September 15,

    2022, Tirzepatide was also approved by the European Commission.

    Items Specifications
    Storage temp.  Store at -20°C
    Color  White to off-white
    Form  Solid

    Basic Info
    Product Name:

    Tirzepatide

    Other Name:

    LY3298176;

    CAS No.:

    2023788-19-2

    Molecular Formula:

    C225H348N48O68

    Molecular Weight:

    4813

    EC Number:

    200-001-8

    Categories:

    Other Chemical Drugs

    Characteristics
    Appearance:

    White to off-white

  • Seller Information
    Business Type:

    Distributor

    Main Products:

    API,Intermediate

    Payment Terms:

    TT against copy of documents,L/C

    Average lead Time:

    30

    Total Annual Revenue:

    Above $100 million

    Total Employees:

    201-300

    About Echemi Pharmaceutical 

    Echemi’s philosophy is to seek for higher quality, to explore frontier area. The progress of human society, the extension of life expectancy, and the conquest of disease are all derived from the numerous businesses and individuals who have quietly dedicated themselves in the pharmaceutical industry. It’s the controlling of supply chain quality that ensures the efficacy. It’s the continuous exploration that promotes the development of the pharmaceutical industry and benefits more future generations. The pursuit of high quality requires all partners of Echemi Pharmaceutical to be screened, whether its certificate, qualification or scale. In the field of renewal, we will embrace all new changes and make more contributions to the development of pharmaceutical industry.

    5c54b7e7a92e19d38f90f7daf858e202.png

    Advantage for Pharmaceutical 

    • Having been working in pharmaceutical field for more then 15 years, we have experienced regulatory team, quality control team, sourcing team, technical support team, and logistics team. And we are familiar with the regulatory requirements from different areas, can offer tailored service for our customers.

    • We have hundreds of strategic partners for APIs, intermediates, and custom synthesis. All of our partners are ready to support our customers with documents, and be audited.

    • We can offer custom synthesis for some new chemical structures and some materials which there are no reliable suppliers.

    2c0ca90da4086f3a1b7df867d79e8bba.png

    Product Category 

    We care for human and animal health and we are committed to creating a better social environment.

    •  Human API

    • Intermediate

    • Veterinary API

    • Agrochemical

    • Fine Chemical

    • Custom Synthesis



  • Inquiry History
    1967 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    2023788-19-2 in unlabeled vials 10, 15 and 30 mg

    10  Feb 14, 2024
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss 399 Inquiries

    10 MG Apr 3, 2024
    United States

    Tirzepatide Raw Powder Weight Loss Peptides CAS No 2023788-19-2 Tirzepatide Injection Peptides

    2 MT Dec 13, 2025
    Germany

    2023788-19-2

    1 MG Jun 18, 2026
    United States

    2023788-19-2 Retatrutide

    1 G Sep 22, 2023
    United States

    Tirzepatide 2023788-19-2

    Feb 19, 2024
    United States

    Tirzepatide 2023788-19-2

    10 G Oct 31, 2023
    United States

    2023788-19-2 Trizepatide

    10 MT Oct 29, 2023
    United States

    Trizepatide 2023788-19-2 Raw Material LY3298176 Tirzepatide powder

    Dec 2, 2025
    United States

    Peptide drug GLP-1 Agonists Tirzepatide CAS 2023788-19-2 Weight loss

    2 KG Oct 20, 2023
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    50  Aug 17, 2023
    United States

    Fat Burning Peptides Tirzepatide 10mg/Vial 15mg/Vial Tirzepatide CAS: 2023788-19-2

    1 MT Jan 25, 2024
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    1 MT Oct 20, 2023
    United States

    Pharmacy Grade CAS 2023788-19-2 Tirzepatide 99% White powder Tirzepatide

    10  Aug 3, 2023
    United States

    supply Tirzepatide Safe Material Shipping Trizepatide 2023788-19-2 Raw Tirzepatide powder

    10 MG Apr 4, 2024
    United States

    COA Offer Top quality Weight Loss Peptides Tirzepatide 10mg/vial GLP-1 2023788-19-2

    1 MT Sep 10, 2023
    Kenya

    Janoshik Test Tirzepatide 99% White powder High Quality Tirzepatide Weight loss CAS 2023788-19-2

    30 MG Dec 26, 2025
    United States

    Ex-factory price tirzepatide T30 10vials 30mg kit cas 2023788-19-2 for weight loss peptide

    10  Dec 30, 2024
    United Kingdom

    Manufacturer supply high quality hot sale lowest price Tirzepatide CAS NO,2023788-19-2 99% powder 2023788-19-2 Claire

    100 G Nov 4, 2023
    Canada

    99.9% Purity GLP-1 Injection Weight Loss Peptides Liraglutide Retatrutide Tirzepatide Semaglutide 5mg 10mg CAS 2023788-19-2

    2 MT Oct 22, 2023
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.